Ocugen | 8-K: Current report
Apr 29 20:03
Ocugen | S-3: Registration statement for specified transactions by certain issuers
Apr 19 02:18
Ocugen | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Apr 19 02:18
Ocugen | 8-K: Ocugen Announces U.S. Food and Drug Administration Approval of IND Amendment to Initiate OCU400 Phase 3 Clinical Trial
Apr 9 01:17
Ocugen | 8-K: Ocugen Reports Year End 2023 Financial Results and Provides Corporate Update
Apr 2 21:29
Ocugen | 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Apr 2 05:15
Ocugen | NT 10-K: Others
Apr 2 05:09
Ocugen | 8-K: United States Court of Appeals for the Third Circuit Affirmed the Decision of Consolidated Securities Class Action Lawsuit
Mar 22 04:24
Ocugen | 8-K: Director Patrick Grady Will Not Run For Re-Election At The 2024 Shareholder Meeting
Mar 21 05:18
Ocugen | 8-K: Ocugen Announces Appointment of Huma Qamar as Chief Medical Officer
Mar 18 20:54
Ocugen | 8-K: Presentation of an In-Person Clinical Showcase at the Nasdaq Market Site in Times Square
Feb 22 00:26
Ocugen | 8-K: Ocugen Grants Performance-Based Restricted Stock Units to Incentive Recipients
Jan 8 13:00
Ocugen | 8-K: Ocugen Gains FDA Alignment on Key Aspects of OCU400 Modifier Gene Therapy Pivotal Phase 3 Study Design
Dec 23, 2023 04:09
Ocugen | 8-K: Ocugen Posted Presentation of Courageous Innovation
Nov 9, 2023 21:02
Ocugen | 8-K: Ocugen Provides Business Update with Third Quarter 2023 Financial Results
Nov 9, 2023 20:02
Ocugen | 8-K: Current report
Nov 2, 2023 06:18
Ocugen | 8-K: Ocugen Mucosal Vaccine Candidate OCU500 Selected by NIH/NIAID Project NextGen for Inclusion in Clinical Trials
Oct 10, 2023 21:05
Ocugen | 8-K: Ocugen Board of Directors Appointed Michael Breininger as the Interim Chief Accounting Officer and Principal Financial Officer
Sep 20, 2023 04:54
Ocugen | 8-K: Ocugen Announces Positive Clinical Study Update from the Phase 1/2 Trial of OCU400
Sep 13, 2023 20:28
Ocugen | 8-K: Earnings Release Presentation
Aug 22, 2023 21:12
No Data
No Data